Arkolith/Insider Trading/NAVB/Form 4

Scott John K Jr.

Director, 10% OwnerNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Dec 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 27, 2023Other(J)2K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 27, 2023Other(J)2K$1000.00$2.4M0
Nov 27, 2023Other(J)64K$100.00$6.4M64K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-015898) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML